NCT01736592Active, not recruitingPhase 2
Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular Degeneration
An Open Label Study to Determine the Long Term Safety, Tolerability and Biological Activity of SAR422459 in Patients With Stargardt's Macular Degeneration
Source: ClinicalTrials.gov · Last updated 26 Aug 2026
Brief summary (registry, in English)
Primary Objective: To evaluate the long-term safety and tolerability of SAR422459 in patients with Stargardt's Macular Degeneration. Secondary Objective: To assess: * Safety * Biological activity
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 27 (actual)
- First submitted
- 26 Nov 2012
- Start date
- 14 Dec 2012
- Primary completion date
- 29 Aug 2033
- Lead sponsor
- Sanofi
- Diseases
- Macular degeneration
- NCT number
- NCT01736592
- EudraCT number
- 2012-001990-95
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 27
- From 14 Dec 2012 to the primary completion date, 29 Aug 2033
- 2 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- The following would exclude Patients from participation in the study:
- 1\. Did not receive SAR422459 as part of the TDU13583 protocol.
Who the study is looking for
- Patients must meet ALL of the following criteria:
- Provide signed and dated written informed consent and any locally required authorization (e.g., Health Insurance Portability and Accountability Act \[HIPAA\])
- Must have been enrolled in protocol TDU13583 (SG1/001/10)
- Must have received a subretinal injection of SAR422459
- Must have completed protocol TDU13583 to Week 48 or undergone an early discontinuation visit.
Age in the registry: 6 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Investigational Site Number : 250001 Coordinator of this site? Confirm its status | Paris | France | Unknown status |
| Oregon Health and Science University Site Number : 840001 Coordinator of this site? Confirm its status | Portland | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.